共 182 条
[11]
LaCroix AZ(1999)Effect of alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis JAMA 282 1344-1443
[12]
Black DM(1995)Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures N Engl J Med 333 1437-1341
[13]
Yates J(1996)Fracture risk reduction with alendronate in women osteoporosis: the fracture intervention trial: FIT research group Lancet 348 1535-4124
[14]
Rodan GA(2000)Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial J Clin Endocrinol Metab 85 4118-415
[15]
McClung M(2002)Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group J Am Geratr Soc 50 409-12
[16]
Bensen W(2002)Alendronate Once-Weekly Study Group: Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis Aging (Milano) 12 1-1996
[17]
Bologne M(2002)A comparison of the effect of risedronate and ethidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial J Bone Miner Res 17 1988-979
[18]
Clemmesen B(2002)Postmenopozal osteoporozda ethidronat ve alendronat tedavilerinin karsilastirilmasi Osteoporos Int 13 971-137
[19]
Ravn P(1999)A comparison of continuous alendronate, cyclical alaendronate and cyclical ethidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial Cukurova Universitesi Tip Fakultesi Dergisi 24 125-966
[20]
Zegels B(2000)Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomized, placebo-controlled study Osteoporos Int 11 956-12